Dr. Jonathann Kuo

Extension is like, how do we optimize, you know, beyond the work I do with like enhanced game and optimizing humans to the next level, the same techniques apply to almost, you know, everyday humans.

Like it's the basic same physiological systems, the same cellular health that you need to optimize.

And so the strategies are really the same.

What do you think about that?

I mean, it's a trend.

I mean, I think it's... You know, people are like, you know, buying...

research peptides on Telegram and injecting them for looks maxing.

And I think that part's dangerous.

You know, the whole research peptide kind of craze out there is really concerning.

It's nuts.

Yeah, yeah.

There's just hundreds and hundreds of websites.

I mean, because the demand is just there.

Insane.

Insane.

But, you know...

FDA is hopefully going to make those changes in June, July, reclassifying some peptides from Category 2 to 1.

And I hope that really opens up the market.

What does that mean when they do Category 2 to 1?

They're going to allow compounding of some of these peptides that, you know, they previously put on the do not compound list.